Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Percy Ivy

Showing results (51-60 of 232) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer SubjectsAaron S Mansfield, Michelle A Rudek, Diana Vulih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to M. Voskoboynik et alDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Challenges and Opportunities in Adapting Clinical Trial Design for ImmunotherapiesLillian L Siu, S Percy Ivy, Erica L Dixon, et al.
Investigational New Drugs|June 11, 2003
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancerSanjay Goel, Scott Wadler, Anthony Hoffman, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitorEmily S Robinson, Ursula A Matulonis, Percy Ivy, et al.
Journal of Hematology & Oncology|February 6, 2015
Notch1 phenotype and clinical stage progression in non-small cell lung cancerDat Nguyen, Larry Rubinstein, Naoko Takebe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical TrialsShing M Lee, Daniel Backenroth, Ying Kuen Ken Cheung, et al.
Pageof 24

Showing results (51-60 of 232) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer SubjectsAaron S Mansfield, Michelle A Rudek, Diana Vulih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to M. Voskoboynik et alDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Challenges and Opportunities in Adapting Clinical Trial Design for ImmunotherapiesLillian L Siu, S Percy Ivy, Erica L Dixon, et al.
Investigational New Drugs|June 11, 2003
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancerSanjay Goel, Scott Wadler, Anthony Hoffman, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitorEmily S Robinson, Ursula A Matulonis, Percy Ivy, et al.
Journal of Hematology & Oncology|February 6, 2015
Notch1 phenotype and clinical stage progression in non-small cell lung cancerDat Nguyen, Larry Rubinstein, Naoko Takebe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical TrialsShing M Lee, Daniel Backenroth, Ying Kuen Ken Cheung, et al.
Pageof 24